CHMP recommends change in terms of marketing authorization for Nevanac

The Committee for Medicinal Products for Human Use adopted a positive opinion recommending a change to the terms of the marketing authorization for Nevanac, according to a summary of opinion from the European Medicines Agency. The recommended change is an extended indication that states “Nevanac 3 mg/mL is indicated in adults for prevention and treatment of postoperative pain and inflammation associated with cataract surgery [and] reduction in the risk of preoperative macular edema associated with cataract surgery in diabetic patients,” the opinion said.

ManagementPlus Launches Revenue Cycle Solutions (RCS) at Optometry’s Meeting

BOSTON–(BUSINESS WIRE)–ManagementPlus, an ECL Group affiliate company and a leader in EHR solutions, announced today that it will launch its Revenue Cycle Solutions (RCS) at the annual Optometry’s Meeting in Boston from June 29-July 3. The company will also be exhibiting at booth #513 and will join hundreds of optometry professionals at the official annual meeting of the American Optometric Association (AOA) and the American Optometric Student Association (AOSA). ManagementPlus incorporates a